Care Capital Investments III L.P.
Insider CIK 1599355 · AGRX 10% owner · ITEK 10% owner · NRX Director, 10% owner · CLCD 10% owner · NERV 10% owner · AVIR 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVIR Vaxart, Inc. | A Award | 2018-02-13 | 2018-02-15 | 30,793,670 | — | $0 | 30,793,670 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | A Award deriv | 2015-06-24 | 2015-06-26 | 12,000 | $5.03 | $60.4K | 21,857 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-12 | 20,050 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-12 | 1,199,841 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-12 | 320,295 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-12 | 5,353 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-12 | 1,520,136 | — | $0 | 1,520,136 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-12 | 25,403 | — | $0 | 25,403 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | A Award deriv | 2015-05-05 | 2015-05-07 | 5,954 | — | $0 | 5,954 | SEC↗ |
| NERV Minerva Neurosciences, Inc | S Sale | 2015-03-18 | 2015-03-20 | 6,700 | $6.25 | $41.9K | 1,662,592 | SEC↗ |
| NERV Minerva Neurosciences, Inc | S Sale | 2015-03-18 | 2015-03-20 | 1,200,000 | $5.75 | $6.90M | 1,669,292 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion deriv | 2015-02-23 | 2015-02-25 | 0 | — | $0 | 0 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion deriv | 2015-02-23 | 2015-02-25 | 4,459,658 | — | $0 | 0 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion | 2015-02-23 | 2015-02-25 | 63,560 | — | $0 | 1,673,307 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | P Buy | 2015-02-23 | 2015-02-25 | 603,832 | $6.00 | $3.62M | 2,277,139 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion | 2015-02-23 | 2015-02-25 | 1,394,645 | — | $0 | 1,609,747 | SEC↗ |
| NERV Minerva Neurosciences, Inc | S Sale | 2015-01-26 | 2015-01-26 | 23,111 | $5.02 | $116.0K | 2,869,292 | SEC↗ |
| NERV Minerva Neurosciences, Inc | S Sale | 2015-01-23 | 2015-01-26 | 63,304 | $5.14 | $325.4K | 2,892,403 | SEC↗ |
| NERV Minerva Neurosciences, Inc | S Sale | 2015-01-22 | 2015-01-26 | 395,697 | $5.11 | $2.02M | 2,955,707 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | P Buy deriv | 2015-01-12 | 2015-05-07 | 320,295 | — | $0 | 320,295 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | P Buy deriv | 2015-01-12 | 2015-05-07 | 16,041 | — | $0 | 16,041 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | P Buy deriv | 2015-01-12 | 2015-05-07 | 5,353 | — | $0 | 5,353 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | P Buy deriv | 2015-01-12 | 2015-05-07 | 959,872 | — | $0 | 959,872 | SEC↗ |
| NERV Minerva Neurosciences, Inc | S Sale | 2015-01-08 | 2015-01-08 | 70,659 | $5.66 | $399.9K | 3,351,404 | SEC↗ |
| NERV Minerva Neurosciences, Inc | S Sale | 2015-01-07 | 2015-01-08 | 64,278 | $5.85 | $376.0K | 3,422,063 | SEC↗ |
| NERV Minerva Neurosciences, Inc | S Sale | 2015-01-06 | 2015-01-08 | 396,871 | $7.94 | $3.15M | 3,486,341 | SEC↗ |
| NERV Minerva Neurosciences, Inc | C Conversion deriv | 2014-07-07 | 2014-07-09 | 61,923 | $6.00 | $371.5K | 0 | SEC↗ |
| NERV Minerva Neurosciences, Inc | C Conversion deriv | 2014-07-07 | 2014-07-09 | 114,078 | $6.00 | $684.5K | 0 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2014-07-07 | 2014-07-09 | 737,500 | $6.00 | $4.42M | 3,883,212 | SEC↗ |
| NERV Minerva Neurosciences, Inc | C Conversion | 2014-07-07 | 2014-07-09 | 61,923 | $6.00 | $371.5K | 3,145,712 | SEC↗ |
| NERV Minerva Neurosciences, Inc | C Conversion | 2014-07-07 | 2014-07-09 | 114,078 | $6.00 | $684.5K | 3,083,789 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | C Conversion deriv | 2014-05-29 | 2014-05-29 | 1,393,000 | — | $0 | 0 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | C Conversion deriv | 2014-05-29 | 2014-05-29 | 303,255 | — | $0 | 0 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | C Conversion deriv | 2014-05-29 | 2014-05-29 | 135,432 | — | $0 | 0 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | C Conversion | 2014-05-29 | 2014-05-29 | 424,557 | — | $0 | 2,374,757 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | P Buy | 2014-05-29 | 2014-05-29 | 500,000 | $6.00 | $3.00M | 3,010,189 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | C Conversion | 2014-05-29 | 2014-05-29 | 135,432 | — | $0 | 2,510,189 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | C Conversion | 2014-05-29 | 2014-05-29 | 1,950,200 | — | $0 | 1,950,200 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 5,781,269 | — | $0 | 5,785,962 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 13,964,398 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 5,785,962 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 0 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | P Buy | 2014-02-14 | 2014-02-19 | 790,000 | $12.00 | $9.48M | 4,241,097 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion | 2014-02-14 | 2014-02-19 | 2,148,365 | — | $0 | 2,148,365 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion | 2014-02-14 | 2014-02-19 | 890,140 | — | $0 | 3,038,505 | SEC↗ |
| NRX NephroGenex, Inc. | A Award | 2014-02-14 | 2014-02-19 | 412,592 | — | $0 | 3,451,097 | SEC↗ |